YOUR BUSINESS AUTHORITY
Springfield, MO
Novo Nordisk is cutting direct-to-consumer prices for weight loss drug Wegovy and diabetes counterpart Ozempic, CNBC reports.
The price of the drugs is dropping to $349 per month from $499 per month for existing cash-paying patients. The highest dose of Ozempic will remain at $499 per month.
Novo Nordisk also is launching a temporary introductory offer for the drugs. Patients can receive the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment.
Read more from CNBC.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
State awards Springfield $4.6M for wastewater system improvements
Stockton district names next superintendent
Trump, fast-food companies among targets of X redirects
Council modifies data center definitions bill, extends moratorium into next year